John A. Barrett
No más puestos en curso
Historial de carrera de John A. Barrett
Antiguos cargos conocidos de John A. Barrett.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Director/Miembro de la Junta | - | 10/03/2005 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | 01/01/2000 | 01/01/2003 |
| ALAUNOS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
| PHIO PHARMACEUTICALS CORP. | Corporate Officer/Principal | 22/04/2019 | - |
| Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Director Técnico/Científico/I+D | 01/01/1993 | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 01/08/2005 | - |
Formación de John A. Barrett.
| St. John's University | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
Operativa
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Distribution Services |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Empresas privadas | 4 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Rorer Pharmaceuticals, Inc. |
- Bolsa de valores
- Insiders
- John A. Barrett
- Experiencia
